The landscape of dementia prognosis has evolved significantly with the appearance of complex biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks that could detect Alzheimer's pathology a long time before signs or symptoms emerge. Though these technological advancements signify extraordinary progress in understanding neurodegenerative conditions, they've not https://charlesp541oyh1.smblogsites.com/profile